Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Update Il y a 4 ans
Reference: NCT00526669

Woman and Man

Extract

The study will determine if changes in expression of markers involved in the 5-FU pathways are associated with response to treatment with the combination of lapatinib and capecitabine independent of tumor erbB2 status.


Inclusion criteria

  • Neoplasms, Gastrointestinal Tract


Links